The University of Chicago Header Logo

Connection

Evgeny Izumchenko to Tumor Burden

Back to Details
This is a "connection" page, showing publications Evgeny Izumchenko has written about Tumor Burden.
Evgeny Izumchenko
Connection Strength
0.083
Tumor Burden
  1. In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma. Aging (Albany NY). 2020 11 16; 12(22):22949-22974.
    View in: PubMed
    Score: 0.042
  2. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Sci Signal. 2020 08 18; 13(645).
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.